JPH04270267A - Production of 7-chloroquinaldine - Google Patents

Production of 7-chloroquinaldine

Info

Publication number
JPH04270267A
JPH04270267A JP5073791A JP5073791A JPH04270267A JP H04270267 A JPH04270267 A JP H04270267A JP 5073791 A JP5073791 A JP 5073791A JP 5073791 A JP5073791 A JP 5073791A JP H04270267 A JPH04270267 A JP H04270267A
Authority
JP
Japan
Prior art keywords
chloroquinaldine
acid
nitrobenzaldehyde
reaction
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5073791A
Other languages
Japanese (ja)
Inventor
Yasuo Yoshida
康夫 吉田
Yoshinori Saito
嘉則 斉藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ihara Chemical Industry Co Ltd
Original Assignee
Ihara Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ihara Chemical Industry Co Ltd filed Critical Ihara Chemical Industry Co Ltd
Priority to JP5073791A priority Critical patent/JPH04270267A/en
Publication of JPH04270267A publication Critical patent/JPH04270267A/en
Pending legal-status Critical Current

Links

Landscapes

  • Quinoline Compounds (AREA)

Abstract

PURPOSE:To obtain high-purity 7-chloroquinaldine in an industrial way in high yield. CONSTITUTION:A reaction is made in an inert solvent in the presence of a base between 4-fluoro-2-nitrobenzaldehyde and acetone followed by ring closure reaction simultaneously with reduction in the presence of an acid, thus obtaining a high-purity 5-fluoro-2-halomethylbenzothiazole in high yield.

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明は、坑炎症剤の合成中間体
として有用な高純度の7−クロロキナルジンの製造方法
に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing highly purified 7-chloroquinaldine, which is useful as an intermediate for the synthesis of anti-inflammatory agents.

【0002】0002

【従来の技術】7−クロロキナルジンの製造方法として
は、ジャ−ナル・オブ・オ−ガニックケミストリ−,8
巻,544頁(1943年)において、鉱酸の存在下ク
ロトンアルデヒドとメタクロロアニリンを反応させる方
法が知られている。上記の方法では、7−クロロキナル
ジンと5−クロロキナルジン(以下異性体は同意とする
。)の組成比が7:3の混合物が収率60%で得られる
が、その混合物より7−クロロキナルジンを分離し、医
薬品の原料として要求される高純度の7−クロロキナル
ジンを得ることは難しかった。
[Prior Art] A method for producing 7-chloroquinaldine is described in Journal of Organic Chemistry, 8.
Vol., page 544 (1943), a method is known in which crotonaldehyde and metachloroaniline are reacted in the presence of a mineral acid. In the above method, a mixture of 7-chloroquinaldine and 5-chloroquinaldine (isomers are hereinafter referred to as the same) with a composition ratio of 7:3 can be obtained with a yield of 60%. It has been difficult to separate chloroquinaldine and obtain highly purified 7-chloroquinaldine, which is required as a raw material for pharmaceuticals.

【0003】一方、無置換のキナルジンの製造方法とし
ては、ベリヒテ・デア・オ−ガニッシェン・ヘミ−,4
1巻,2692頁(1908年)において、オルソニト
ロベンズアルデヒドとアセトンを反応させ、更にニトロ
基を亜鉛粉末で還元すると同時に閉環させる事により無
置換のキナルジンを得る方法が提案されているが、収率
は50%と低く工業的な製造法としてはいまだ十分では
なかった。
On the other hand, as a method for producing unsubstituted quinaldine, Berichte der Organischen Hemie, 4
Vol. 1, p. 2692 (1908) proposes a method for obtaining unsubstituted quinaldine by reacting orthonitrobenzaldehyde with acetone, further reducing the nitro group with zinc powder, and simultaneously ring-closing it, but the yield is low. was as low as 50%, which was still not sufficient for an industrial production method.

【0004】0004

【発明が解決しようとする課題】本発明は、従来法の問
題点を解決し異性体が生成しない方法で、高純度の7−
クロロキナルジンを収率良く得る方法を提供するためな
されたものである。
[Problems to be Solved by the Invention] The present invention solves the problems of conventional methods and is a method that does not produce isomers, and is capable of producing highly pure 7-7-
This was done to provide a method for obtaining chloroquinaldine with good yield.

【0005】[0005]

【課題を解決するための手段】本発明者はこのような状
況に鑑み、医薬品の原料として要望されている異性体を
含まない7−クロロキナルジンの製造方法について研究
を重ねた結果、原料としてベンゼン核にクロロ基が置換
した4−クロロ−2−ニトロベンズアルデヒドを用いア
セトンと反応させたところ、反応がスムーズに進行し油
状物が得られた。この油状物を更に還元と同時に閉環さ
せ、異性体を含まない高純度の7−クロロキナルジンが
高収率で得られる事を認め本発明の完成した。
[Means for Solving the Problems] In view of the above circumstances, the present inventor has conducted repeated research on a method for producing 7-chloroquinaldine, which does not contain isomers and is desired as a raw material for pharmaceuticals. When 4-chloro-2-nitrobenzaldehyde in which the benzene nucleus was substituted with a chloro group was reacted with acetone, the reaction proceeded smoothly and an oily substance was obtained. This oil was further reduced and ring-closed at the same time, and it was recognized that highly pure 7-chloroquinaldine containing no isomers could be obtained in high yield, and the present invention was completed.

【0006】すなわち、本発明は、塩基の存在下、4−
クロロ−2−ニトロベンズアルデヒドとアセトンを反応
させ、更に酸の存在下還元と同時に閉環反応させること
を特徴とする7−クロロキナルジンの製造方法を提供す
るものである。
That is, the present invention provides 4-
The present invention provides a method for producing 7-chloroquinaldine, which is characterized by reacting chloro-2-nitrobenzaldehyde and acetone, and further carrying out reduction and ring-closing reactions simultaneously in the presence of an acid.

【0007】以下に本発明を詳細に説明する。まず本発
明の操作としては、塩基の存在下4−クロロ−2−ニト
ロベンズアルデヒドとアセトンを反応し油状物を得る。 その際使用する塩基としては、水酸化ナトリウム、水酸
化カリウム、水酸化リチウム、炭酸ナトリウム、炭酸カ
リウム、炭酸水素ナトリウム、炭酸水素カリウム、炭酸
リチウム、水酸化カルシウム、リン酸三ナトリウム、リ
ン酸水素二ナトリウム、リン酸二水素ナトリウム、フッ
化カリウムなどの無機塩基、あるいはトリエチルアミン
、ピリジン、ジアザビシクロ[2.2.2]オクタン、
ジアザビシクロウンデセンなどの有機塩基が使用できる
が、中でも水酸化ナトリウム、炭酸ナトリウム、リン酸
ナトリウム類などの無機塩基の使用が好ましい。また上
記無機塩基は、水溶液で使用しても何ら差し支え無い。
The present invention will be explained in detail below. First, in the operation of the present invention, 4-chloro-2-nitrobenzaldehyde and acetone are reacted in the presence of a base to obtain an oily substance. The bases used in this case include sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, lithium carbonate, calcium hydroxide, trisodium phosphate, and dihydrogen phosphate. Inorganic bases such as sodium, sodium dihydrogen phosphate, potassium fluoride, or triethylamine, pyridine, diazabicyclo[2.2.2]octane,
Although organic bases such as diazabicycloundecene can be used, inorganic bases such as sodium hydroxide, sodium carbonate, and sodium phosphates are preferably used. Moreover, the above-mentioned inorganic base may be used in an aqueous solution without any problem.

【0008】なお、4−クロロ−2−ニトロベンズアル
デヒドとアセトンのモル比は、いずれを過剰に用しても
良いが、通常はアセトンを等モル以上、好ましくは5〜
20倍モル以上使用する。反応温度は、室温以下で十分
に進行するが−50〜50℃、好ましくは0〜20℃で
ある。
Regarding the molar ratio of 4-chloro-2-nitrobenzaldehyde and acetone, either may be used in excess, but usually the molar ratio of acetone is equal to or more, preferably 5 to 5.
Use 20 times the mole or more. The reaction temperature is -50 to 50°C, preferably 0 to 20°C, although the reaction proceeds satisfactorily below room temperature.

【0009】次いで得られた油状物を、還元剤で還元す
ると閉環反応が起こり7−クロロキナルジンが得られる
。その際使用する還元剤としては、鉄、亜鉛、錫などの
金属粉末、硫化ナトリウム、水硫化ナトリウム、亜二チ
オン酸ナトリウム、などの硫黄化合物などが使用できる
。また、ラネ−ニッケル、パラジウム炭素、酸化白金な
どを触媒として用い、接触水素化を行っても良い。中で
も、鉄粉による還元、もしくは接触水素化が工業的には
好ましい。また還元剤の使用量は、4−クロロ−2−ニ
トロベンズアルデヒドを基準にし、還元剤を1〜5倍当
量、好ましくは1〜1.2倍当量使用する。
[0009] Next, the obtained oil is reduced with a reducing agent to cause a ring-closing reaction and to obtain 7-chloroquinaldine. As the reducing agent used in this case, metal powders such as iron, zinc, and tin, and sulfur compounds such as sodium sulfide, sodium hydrosulfide, and sodium dithionite can be used. Catalytic hydrogenation may also be carried out using Raney nickel, palladium on carbon, platinum oxide, or the like as a catalyst. Among these, reduction with iron powder or catalytic hydrogenation is industrially preferred. The amount of the reducing agent to be used is 1 to 5 times equivalent, preferably 1 to 1.2 times equivalent, based on 4-chloro-2-nitrobenzaldehyde.

【0010】また酸としては、塩酸、硫酸、硝酸、など
の鉱酸類、あるいは酢酸、トリフルオロ酢酸、メタンス
ルホン酸、トリフルオロメタンスルホン酸、ベンゼンス
ルホン酸、パラトルエンスルホン酸、などの有機酸類が
使用されるが、これらの酸は、単独で用いても良いが2
種類以上混合して用いても良い。中でも塩酸、硫酸、酢
酸等の使用が好ましい。酸の使用量は特に制限はないが
、水で希釈し溶媒を兼ねて用いるても良く、必要があれ
ば他の溶媒を添加しても差し支え無い。反応温度は室温
〜150゜Cであるが、好ましくは40〜100℃であ
る。また反応圧は常圧で十分であるが、加圧下で行って
も良い。尚原料として使用する4−クロロ−2−ニトロ
ベンズアルデヒドは、4−クロロ−2−ニトロトルエン
を臭素化し、更に加水分解することにより容易に得られ
る。
[0010] As the acid, mineral acids such as hydrochloric acid, sulfuric acid, and nitric acid, or organic acids such as acetic acid, trifluoroacetic acid, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, and p-toluenesulfonic acid are used. However, these acids may be used alone, but
More than one kind may be mixed and used. Among them, it is preferable to use hydrochloric acid, sulfuric acid, acetic acid, etc. There is no particular restriction on the amount of acid used, but it may be diluted with water and used also as a solvent, and other solvents may be added if necessary. The reaction temperature is from room temperature to 150°C, preferably from 40 to 100°C. Further, although normal pressure is sufficient as the reaction pressure, the reaction may be carried out under increased pressure. Note that 4-chloro-2-nitrobenzaldehyde used as a raw material can be easily obtained by brominating 4-chloro-2-nitrotoluene and further hydrolyzing it.

【0011】[0011]

【発明の効果】本発明の方法は、塩基の存在下、原料と
してベンゼン核に塩素の置換した4−クロロ−2−ニト
ロベンズアルデヒドを使用し、アセトンと反応させるよ
うにしたので反応がスムーズに進行し油状物が得られた
。得られた油状物は、更に酸の存在下還元すると閉環反
応が同時に起こり、高純度の7−クロロキナルジンが高
収率で得られたものである。この様に本発明の方法は、
従来法のように5−クロロキナルジン(異性体)の分離
の必要も無く、坑炎症剤(医薬品)の原料として要望さ
れる高純度の7−クロロキナルジンが提供できるように
成ったものである。以下、実施例により本発明を具体的
に示す。
[Effects of the Invention] The method of the present invention uses 4-chloro-2-nitrobenzaldehyde in which the benzene nucleus is substituted with chlorine as a raw material and reacts it with acetone in the presence of a base, so that the reaction proceeds smoothly. An oily substance was obtained. When the obtained oil was further reduced in the presence of an acid, a ring-closing reaction occurred at the same time, and highly purified 7-chloroquinaldine was obtained in a high yield. In this way, the method of the present invention
Unlike conventional methods, there is no need to separate 5-chloroquinaldine (isomers), and it is now possible to provide highly pure 7-chloroquinaldine, which is required as a raw material for anti-inflammatory agents (medicines). be. Hereinafter, the present invention will be specifically illustrated by examples.

【0012】0012

【実施例1】温度計、攪拌機および還流冷却管を備えた
四口フラスコに、4−クロロ−2−ニトロベンズアルデ
ヒド18.6g(100ミリモル)、アセトン100m
lおよび水50mlを仕込み、氷水で10〜15℃に冷
却した。続いて無水炭酸ナトリウム2.1g(20ミリ
モル)を水50mlに溶解し、攪拌しながら同温度で3
0分間滴下し、更に2時間攪拌を続けた。反応終了後1
Nの塩酸を溶液のPHが3〜4℃となるまで滴下した。 アセトンを留去し水100mlを加え、更にジクロロメ
タン500mlで2回抽出した。有機層を、無水炭酸ナ
トリウムで乾燥後留去し、25.0gの淡褐色油状物質
を得た。
[Example 1] In a four-necked flask equipped with a thermometer, a stirrer, and a reflux condenser, 18.6 g (100 mmol) of 4-chloro-2-nitrobenzaldehyde and 100 ml of acetone were placed.
1 and 50 ml of water were added, and the mixture was cooled to 10-15°C with ice water. Next, 2.1 g (20 mmol) of anhydrous sodium carbonate was dissolved in 50 ml of water, and the mixture was heated at the same temperature with stirring for 30 minutes.
The mixture was added dropwise for 0 minutes, and stirring was continued for an additional 2 hours. After the reaction 1
N hydrochloric acid was added dropwise until the pH of the solution reached 3 to 4°C. Acetone was distilled off, 100 ml of water was added, and the mixture was further extracted twice with 500 ml of dichloromethane. The organic layer was dried over anhydrous sodium carbonate and then evaporated to obtain 25.0 g of a light brown oily substance.

【0013】更に、上記淡褐色油状物質25.0gと酢
酸100ml、35%塩酸50mlを温度計、攪拌機お
よび還流冷却管を備えた四口フラスコに、室温で鉄粉2
2.3g(0.4モル)を徐々に加えた。発熱が始まり
、反応温度は70℃に上昇した。発熱終了後、オイルバ
ス上で加熱し、80℃で更に2.5時間攪拌した。その
間更に鉄粉5.6g(0.1モル)を加えた。反応混合
物を冷却し、氷冷下で20%水酸化ナトリウム水溶液9
50ml中に滴下した。ジクロロメタン1300mlで
抽出し、有機層を取り出し水950mlで洗浄した。 その間析出した不溶物は、ケイソウ土で吸引濾過し除去
した。有機層を無水硫酸ナトリウムで乾燥した後濃縮し
、融点73〜75℃の7−クロロキナルジンを15.4
g得た。収率は86.7%であり、純度は99%であっ
た。またガスクロマトグラフィーで分析したところ、異
性体の5−クロロキナルジンは含まれていなかった。
Furthermore, 25.0 g of the light brown oily substance, 100 ml of acetic acid, and 50 ml of 35% hydrochloric acid were placed in a four-necked flask equipped with a thermometer, a stirrer, and a reflux condenser, and 22 g of iron powder was added at room temperature.
2.3 g (0.4 mol) was added gradually. An exotherm began and the reaction temperature rose to 70°C. After the exotherm ended, the mixture was heated on an oil bath and stirred at 80° C. for an additional 2.5 hours. During this time, 5.6 g (0.1 mol) of iron powder was further added. Cool the reaction mixture and add 20% aqueous sodium hydroxide solution 9 under ice cooling.
It was added dropwise into 50ml. Extraction was performed with 1300 ml of dichloromethane, and the organic layer was taken out and washed with 950 ml of water. Insoluble matter precipitated during this period was removed by suction filtration through diatomaceous earth. The organic layer was dried over anhydrous sodium sulfate and then concentrated to give 7-chloroquinaldine with a melting point of 73 to 75°C at 15.4
I got g. The yield was 86.7% and the purity was 99%. Furthermore, analysis by gas chromatography revealed that the isomer 5-chloroquinaldine was not contained.

【0014】[0014]

【実施例2】炭酸ナトリウムの代わりに炭酸カリウムに
代えた以外は、実施例1と同様に行った。その結果、7
−クロロキナルジンを12.9g得た。収率は、72.
6%であり、純度は99%であった。
Example 2 The same procedure as in Example 1 was carried out except that potassium carbonate was used instead of sodium carbonate. As a result, 7
-12.9g of chloroquinaldine was obtained. The yield was 72.
6%, and the purity was 99%.

【実施例3】[Example 3]

【0015】鉄粉を亜鉛粉26.1g(0.4モル)に
代えた以外は、実施例1と同様に行った。その結果、7
−クロロキナルジンを15.2g得た。収率は、85.
6%であり、純度は99%であった。
The same procedure as in Example 1 was carried out except that 26.1 g (0.4 mol) of zinc powder was used instead of iron powder. As a result, 7
-15.2g of chloroquinaldine was obtained. The yield was 85.
6%, and the purity was 99%.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】  塩基の存在下、4−クロロ−2−ニト
ロベンズアルデヒドとアセトンを反応させ、更に酸の存
在下還元と同時に閉環反応させることを特徴とする7−
クロロキナルジンの製造方法。
1. 7-, which is characterized by reacting 4-chloro-2-nitrobenzaldehyde with acetone in the presence of a base, and further carrying out a ring-closing reaction simultaneously with reduction in the presence of an acid.
Method for producing chloroquinaldine.
JP5073791A 1991-02-22 1991-02-22 Production of 7-chloroquinaldine Pending JPH04270267A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5073791A JPH04270267A (en) 1991-02-22 1991-02-22 Production of 7-chloroquinaldine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5073791A JPH04270267A (en) 1991-02-22 1991-02-22 Production of 7-chloroquinaldine

Publications (1)

Publication Number Publication Date
JPH04270267A true JPH04270267A (en) 1992-09-25

Family

ID=12867157

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5073791A Pending JPH04270267A (en) 1991-02-22 1991-02-22 Production of 7-chloroquinaldine

Country Status (1)

Country Link
JP (1) JPH04270267A (en)

Similar Documents

Publication Publication Date Title
KR850000945B1 (en) Process for preparing 5-carbamoyl-10,11-dihydro-5h-dibenz(b,f)azepine
US6215021B1 (en) Trifluoromethylating reagents and synthesizing processes
JP2004516309A (en) Method for producing 1,5-naphthalenediamine
JPH04270267A (en) Production of 7-chloroquinaldine
JPS6145613B2 (en)
JPS5925779B2 (en) Isomerization method for stereoisomeric alicyclic diamines
EP0000152B1 (en) Oxaminic acids and esters, process for their preparation and pharmaceutical compositions containing them
JPS62198678A (en) Manufacture of fluorinated o-diaminobenzo-1,4-dioxenes
JP4258658B2 (en) Method for producing acetylene compound
KR100441348B1 (en) A Method for the Preparation of 6-Morphanthridone, the Intermediate of Epinastine
US4615842A (en) Method for making ethynylated aromatic compounds and a method for making nitronium trifluoromethanesulfonate
KR100486320B1 (en) Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one
JP2893182B1 (en) 2,7-diaza-1,2,3,6,7,8-hexahydropyrene compound and method for producing the same
US3230258A (en) Process for the production of 3-alkyl-6-halogeno-anilines
JPS6344552A (en) 2,6-dichloro-3,4-dinitroethylbenzene and production thereof
JPH03133975A (en) New phenoxythiophene derivative
JPH0588213B2 (en)
JP4956760B2 (en) Method for producing 3-bromobenzoic acid or alkyl ester thereof
JP2685896B2 (en) Cyclopenta [d] pyrimidine derivative and process for producing the same
KR910009236B1 (en) Process for the preparation of n-2'-carboxyl phenyl-4-chloro anthranilic acid
JPS5915919B2 (en) Method for producing (N-methylpyryl-2)acetothioamide derivative
JP2764325B2 (en) 1,3-diamino-2,4-diisopropylbenzene and method for producing the same
JPH027583B2 (en)
JPH0583537B2 (en)
JPH0352839A (en) Production of p-or m-tert-butoxybenzaldehyde